Once-daily Therapy for Streptococcal Pharyngitis
1 other identifier
interventional
N/A
1 country
1
Brief Summary
In some studies once daily amoxicillin therapy might be treatment of choice for Group A β-hemolytic Streptococcus pharyngitis in comparison with three to four times daily treatment with oral penicillin V.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2004
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 7, 2011
CompletedFirst Posted
Study publicly available on registry
March 8, 2011
CompletedMarch 8, 2011
January 1, 2005
March 7, 2011
March 7, 2011
Conditions
Keywords
Study Arms (2)
Amoxicillin
EXPERIMENTALOnce-daily Therapy for Streptococcal Pharyngitis With Amoxicillin
Benzathin Penicillin G
ACTIVE COMPARATOROnce-daily Therapy for Streptococcal Pharyngitis With Intramuscular Benzathin Penicillin G
Interventions
It is mentioned underlined in page 10 in research. (Once the throat swab was taken and cultured on plate at the place where the child was examined, hygiene teacher was trained about how to prepare the oral amoxicillin suspension and how to give it to the child. 750 milligrams of amoxicillin was thereafter given to the patient and in order not to infect other school children, the patient was sent home. The following morning, the patient would come to school and was given the second dose of amoxicillin by the hygiene teacher. All oral drugs were bought from a creditable company. In the injection group, 600000 units of penicillin was administered to children who weigh less than 27 kilograms and 1200000 units of penicillin was administered to children who weigh more. After 48 hours, patients were examined again when the result of first culture was ready)
Eligibility Criteria
You may qualify if:
- Age of 6 to 15 years old.
- The criteria in clinical examination including objective signs (fever, Erythema or exudate of tonsils, enlarged lymph nodes) and subjective sign(sore throat). Neck tenderness, abdominal pain and pharynx petechia were also considered.
- No antibiotic was used during the week before.
- Performing throat culture before the initiation of drug administration
- Positive throat culture indication GABHS
- No previous history of allergy to penicillin .
You may not qualify if:
- Age of below 6 years old or above 15 years old.
- No signs of pharyngitis in the clinical examination
- Antibiotic use during the week before.
- Throat culture was not performed before the initiation of drug administration.
- Negative throat culture or the culture indicates a microorganism other than GABHS.
- History of allergy to penicillin
- Not using drugs or not following the treatment in the field of having the second culture performed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Islamic Azad University
Mashhad, Khorasan, 91796, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 7, 2011
First Posted
March 8, 2011
Study Start
January 1, 2004
Study Completion
March 1, 2006
Last Updated
March 8, 2011
Record last verified: 2005-01